PHAR vs CRMD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

PHAR

42.7
AI Score
VS
CRMD Wins

CRMD

56.9
AI Score

Investment Advisor Scores

PHAR

43score
Recommendation
HOLD

CRMD

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR CRMD Winner
Forward P/E 212.766 46.5116 CRMD
PEG Ratio 0 0 Tie
Revenue Growth -3.2% 156.5% CRMD
Earnings Growth -62.9% 6.7% CRMD
Tradestie Score 42.7/100 56.9/100 CRMD
Profit Margin 2.5% 40.5% CRMD
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PHAR 1M: -12.9% · 3M: -31.9% CRMD 1M: -16.5% · 3M: -18.2%

Current Technical Phase

PHAR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 34

RSI (14): 33.8 · Price: $9.75

CRMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.2%), weak momentum, RSI 32

RSI (14): 31.9 · Price: $7.19

Fundamentals Snapshot

Metric PHAR CRMD
Market Cap — —
Forward P/E 31.8 126.8
Trailing P/E 71.1 3.4
Revenue (TTM) — —
Revenue Growth 0.0% 1.6%
Gross Margin 0.9% 0.9%
Operating Margin 0.0% 0.4%
EPS 0.14 2.18
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRMD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.